Related Experiment Video
Updated: Sep 24, 2025
06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
9.0K
PTEN as a target in melanoma.
Furkan Akif Ince1, Artur Shariev1, Katie Dixon2
1School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Journal of Clinical Pathology
|May 9, 2022
Summary
Phosphatase and tensin homolog (PTEN) protein suppresses tumors by inhibiting the PI3K-AKT pathway. PTEN interactions influence melanoma development, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Phosphatase and tensin homolog (PTEN) is a critical tumor suppressor protein.
- PTEN inactivation is common in various cancers, including melanoma.
- PTEN primarily functions by inhibiting the phosphoinositide 3-kinase-protein kinase B (PI3K-AKT) signaling pathway.
Purpose of the Study:
- To review the role of PTEN in melanoma pathogenesis.
- To discuss how molecular interactions with PTEN affect melanoma.
- To explore the potential of PTEN-targeted therapies for melanoma.
Main Methods:
- Literature review of PTEN in melanoma.
- Analysis of PTEN mutations in melanoma cell lines and tissues.
- Examination of molecular interactions affecting PTEN activity.
Main Results:
- PTEN mutations are frequently identified in melanoma.
- Various molecules modulate PTEN's tumor-suppressive activity in melanoma.
- Interactions can either promote or antagonize PTEN's function against melanoma.
Conclusions:
- PTEN plays a significant role in melanoma development.
- Understanding PTEN's molecular interactions is key to melanoma treatment.
- Targeting PTEN offers a promising therapeutic strategy for melanoma.
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:27Tumor Immunotherapy
681
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
681
01:30Skin Cancer
4.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.7K